Pharmacogenomics

Article	Citations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations	43
Genetics and response to treatment with metformin for type 2 diabetes	28
Assessing patient understanding of pharmacogenomic test results: a qualitative study	28
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans	28
Patient comprehension of preemptive pharmacogenomic results	27
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting	24
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN12	17
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization	13
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review	13
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	12
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis	12
Rapid point of care testing: the next frontier in pharmacogenomics	12
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	12
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates	10
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations	10
Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insight	10
CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations	10
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	10
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention	9
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level	9
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	9
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications	9
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease	8
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor	8
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	8

Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration	8
Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam	8
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi	8
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study	8
Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey	8
Genetic polymorphisms and adverse reactions to antituberculosis therapy	8
A critical review of RAF inhibitors in BRAF-mutated glioma treatment	7
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma	7
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study	7
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	7
Genetika+: Precision Medicine Solutions for Mental Health	7
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics	7
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226	7
The Festival of Genetics and Personalized Medicine	6
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis	6
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience	6
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations	6
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review	6
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data	6
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study	5
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H	5
Understanding variation in metoprolol response: CYP2D6, drug interactions, and phenoconversion	5
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population	5
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions	5
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients	5
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	5
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation	5
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism	5
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients	5
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases	5
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	5
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	5
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients	5
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	5
Pharmacogenomics in Pediatric Medicine and Drug Development	5
Overview of the Year 2023 at Pharmacogenomics	5
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	5
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations	4
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients	4
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury	4
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	4
Impact of ABCB1 gene polymorphism on clopidogrel plasma concentration and cardiovascular events in post-PCI patients	4
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	4
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis	4
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results	4
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	4
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders	4
Pharmacogenomic curriculum in Australian medical schools: a content analysis study	4

Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations	4
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine	4
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	4
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	4
Liquid biopsy: an essential tool for metastatic breast cancer’s follow-up	4
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	4
Variation in the ABC transporter genes and association with clinical outcomes in colorectal cancer: a brief review	4
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	3
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	3
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	3
Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the W	3
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	3
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing	3
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review	3
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors	3
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress	3
Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes	3
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	3
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped	3
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review	3
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes	3
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer	3
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients	3
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	3
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka	3
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	3
Targeting RET mutation in medullary thyroid cancer	3
Genetic polymorphism associated with non-response to therapy in inflammatory bowel disease patients: a review	3
Cancer genetics and response to oncolytic virus treatment for ovarian cancer	3
Pharmacogenomics education among professional societies: assessing practices and future needs	3
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	3
Artificial intelligence, medications, pharmacogenomics, and ethics	3
Pharmacogenetic Informed Care in Early Childhood: Options for Improving Access and Health Equity	3
Pharmacogenetic Variants Influence Vitamin K Anticoagulant Dosing in Patients with Mechanical Prosthetic Heart Valves	3
Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer’s disease	3
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review	3
From genomics to clinic: the transformative impact of AI in pharmacogenomics and personalized medicine	3
Pharmacogenetic markers of PEG-asparaginase toxicity in Brazilian pediatric ALL: insights from a multicenter prospective cohort study	3
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury	3
Pharmacogenetics Research in Brazil: A Systematic Review	2
Implication of KDM6A in Bladder Cancer	2
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	2
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population	2
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders	2
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review	2
Pharmacogenetic Differentiation Across Latin America	2
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	2
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions	2
The genomic landscape of CYP2D6 variation in the Indian population	2
Characterizing models for delivery of pharmacogenomic testing: a scoping review	2
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients	2
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel	2
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada	2
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	2
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic	2
Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia	2
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity	2
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia	2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients	2
Implementation of clopidogrel pharmacogenetics: a Brazilian perspective	2
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics	2
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals	2
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations	2
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence	2
Glaucoma diagnosis and treatment in the era of precision medicine	2
Breast Cancer Pharmacogenetics: A Systematic Review	2
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	2
Warfarin Pharmacogenomics in African Populations: The Importance of Ethnicity-Based Algorithms	2
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	2
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro	2
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma	1
Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell Disease	1
Keeping Pace with CYP2D6 Haplotype Discovery: Innovative Methods to Assign Function	1
Screening and analysis of single nucleotide polymorphism in the 3′-UTR microRNA target regions and its implications for lung tumorigenesis	1
PGxKnow: A Pharmacogenomics Educational Hololens Application of Augmented Reality and Artificial Intelligence	1
Diagnosis and Treatment Monitoring in Breast Cancer: How Liquid Biopsy Can Support Patient Management	1
Association of OPRK1 rs963549 and rs997917 Polymorphisms With Opioid Use Disorder and Related Phenotypes	1
A genome-wide association study of stroke risk in Asian statin users: evidence from KoGES and UK Biobank	1

Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients	1
Application of Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma	1
Genetic polymorphisms of VEGFR2 and FGFR2 genes are associated with exposure to sunitinib and cardiovascul	1
Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe	1
A Single-Tube Multiplex Real-Time PCR for HLA-B*38:02 Genotype by Detecting Highly Specific SNPs	1
Challenges for the Application of Pharmacogenomics Associated with the Nomenclature of Allelic Variants	1
From bench to bedside: a spotlight on pharmacogenomics at Nemours Children’s Health	1
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	1
Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder	1
HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV	1
Clinical Pharmacogenomics Implementation In Thailand: A Dream Come True	1
Pharmacogenomics of Oxcarbazepine in the Treatment of Epilepsy	1
CYP2C18: The Orphan in the CYP2C Family	1
The Role of Alcohol Intake in the Pharmacogenetics of Treatment with Clozapine	1
Pharmacogenomic Markers of Metoprolol and α-OH-Metoprolol Concentrations: A Genome-Wide Association Study	1
Correlation between Methylation Level of the SLC19A1 Promoter Region and Methotrexate Metabolism in Adult Acute Lymphoblastic Leukemia	1
Ethnic differences in pharmacogenomic variants: a south Asian perspective	1
Circulating Tumor DNA-Guided Minimal Residual Disease Assessment in Colorectal Cancer	1
An Alcohol Dehydrogenase 7 Gene Polymorphism Associates with Both Acute and Chronic Pain in Sickle Cell Disease	1
Diversity of Pharmacogenomic Variants Affecting Warfarin Metabolism in Sri Lankans	1
HLA Pharmacogenetic Markers of Drug Hypersensitivity from the Perspective of the Populations of the Greater Middle East	1
Pharmacogenetics to optimize immunosuppressant therapy in systemic lupus erythematosus: a scoping review	1
Scoping review of associations between cytochrome P450 3A4/5 single nucleotide polymorphisms and risk factors for fentanyl overdose	1
Providers’ use of pharmacogenetic testing to inform opioid prescribing among veterans	1
Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review	1
Coriell Life Sciences: Empowering the Most Precise Medical Care for a Healthier World	1
Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations	1
rs144012689 is a Highly Specific Representative Marker of HLA-B*15:02 in the Chinese Population	1
Personalized Anti-Rejection Therapy with Alemtuzumab for Kidney Transplant Recipients	1
ARG2 Single-Nucleotide Polymorphism RS3742879 Affects Plasma Arginase 2 Levels, Nitric Oxide Formation and Antihypertensive Therapy Response in Preeclampsia	1
PMAT Variant Rs3889348 is Associated with Metformin-Induced Gastrointestinal among Chinese Type 2 Diabetes Patients	1
Single-Nucleotide Polymorphism Associations with Efficacy and Toxicity in Metastatic Castration-Resistant Prostate Cancer Treated with Cabazitaxel	1
Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation	1
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention	1
Sertraline Dosing Trends in Children and Adolescents Stratified by CYP2C19 Genotype	1
Association of IL4RA Polymorphism in Predicting Susceptibility Toward Chronic Obstructive Pulmonary Disease	1
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease	1
Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers	1
Impact of Genetic Polymorphisms on Tacrolimus Trough Blood Concentration in Chinese Liver Transplant Recipients	1
Profiling of Pharmacogenomic Variants in CYP2D6 and DPYD in Indigenous Arab Breast Cancer Patients	1
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	1
Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism	1
Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stenting	1
Predicting nifedipine responses in preterm labor: a risk score incorporating ABCG2 polymorphisms and clinical factors	1
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	1
Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair	1
Application of Pharmacogenomics in Supportive Oncology: A Patient Journey	1
Pharmacogenetics of Clopidogrel and Warfarin in the Treatment of Cardiovascular Diseases: An Overview of Reviews	1